Ken Griffin Immuno Precise Antibodies Ltd. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Citadel Advisors LLC holds 14,100 shares of IPA stock, worth $9,588. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,100
Previous 16,300
13.5%
Holding current value
$9,588
Previous $24,000
41.67%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IPA
# of Institutions
22Shares Held
1.66MCall Options Held
14.1KPut Options Held
6.9K-
Ingalls & Snyder LLC New York, NY1.3MShares$880,8990.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny63.9KShares$43,4580.0% of portfolio
-
Bank Of Montreal Toronto, A655.9KShares$37,9820.0% of portfolio
-
Northern Trust Corp Chicago, IL50.7KShares$34,4960.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$28,0160.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $16.9M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...